PCa |
prostate cancer |
PSA |
prostate-specific antigen |
RP |
radical prostatectomy |
RT |
radiation therapy |
ECM |
extracellular matrix |
CDH1 |
E-cadherin |
EMT |
epithelial to mesenchymal transition |
lncRNAs |
long non-coding RNAs |
ER |
estrogen receptor |
eNOS |
endothelial nitric oxide synthase |
HIFs |
hypoxia inducible factors |
HOTS |
H19 Opposite Tumor Suppressor |
E2
|
17β-estradiol |
HYP |
hypoxia |
CoCl2
|
cobalt chloride |
qPCR |
quantitative polymerase chain reaction |
KDR |
vascular endothelial growth factor receptor 2 |
EPO |
erythropoietin |
ChIP |
chromatin immunoprecipitation |
TSS |
transcriptional start site |
HDAC |
histone deacetylases |
VHL |
von Hippel-Lindau tumor suppressor |
Ca2+
|
calcium |
ITGB3 |
β3 integrin subunit |
ITGB4 |
β4 integrin subunit |
ITGA2 |
α2 integrin subunit |
RUNX2 |
Runt-related transcription factor 2 |
H3K27me3 |
trimethylated lysine 27 of histone H3 |
OSCs |
organotypic slice cultures |
CCND1 |
Cyclin D1 |
RNA-ChIP |
RNA chromatin immunoprecipitation |
DMSO |
dimethyl sulfoxide |
EDTA |
ethylenediaminetetraacetic acid |
PBS |
phosphate-buffered saline |